Hi AJL,
I guess the commercial interest depends on your Product specifications and any (hopefully) agreed sampling/analytical methodology if product acceptance is involved.
If ALL the mould results or YM values from both methods are far below acceptance limits (are they?), the commercial interest becomes somewhat, pragmatically, moot.
From a purely Research POV, If results from 2 methods do show a significant, repeatable, discrepancy then the preferred validated method (eg samples sent out to a trusted lab [or 2 labs] give reasonably matching data) is presumably the one which gives higher results. (and particularly if you are the receiver).
Hopefully answers yr OP. 
PS - I just noticed that BAM-2001 do not give an absolute counting method for mould on DG18 agar (only for YM) although APHA-2001 uses a simillar procedure to BAM and does include a typical direct mould counting procedure option.
It is worth noting that your data for these particular Product samples appears to prove that the DG18 methodology of 5 days incubation may sometimes give low results as compared to 7 days and particularly when compared to Petrifilm.
(Although yr older mould data afaik did not show this characteristic).
Since both yeast and mould represent a wide group of species it is hardly surprising IMO that count variations may occur when comparing agars, incubation times etc.between Procedures etc. Frankly I'm more surprised that Petrifilm/reduced incubation time is able to closely match results from DG18 (unless the agars are actually similar [?]). (Also see the incubation times in .png in post 20)